# Final Adversarial Paper Self-Review

Status meanings: **Pass** means the item is supported and clearly stated;
**pass with limitation** means the manuscript is defensible only with the stated
scope; **needs new experiment** means wording cannot close the evidence gap.

## 1. Contribution and method

| Reviewer question | Status | Final assessment |
|---|---|---|
| Is the novelty explicit? | Pass | LLMBO-MO separates advisory LLM preferences from simulator evidence through a screened warm start and a bounded, temporary acquisition-side interface. |
| Are the method inputs, outputs, checks, and fallbacks defined? | Pass | Protocol repair, domain screening, region validation, finite-horizon attenuation, shift clipping, and ordinary-EI recovery are stated before Algorithm 1. |
| Is the formal claim stronger than the evidence? | Pass with limitation | The coupling is mathematically bounded, but the principal experiment compares complete configurations rather than isolating coupling causality. |

## 2. Writing and structure

| Reviewer question | Status | Final assessment |
|---|---|---|
| Does the paper follow one reviewer-facing story? | Pass | The six-section sequence is motivation and prior work, formulation, simulator/proxy, method, validation/discussion, and conclusion. |
| Is prior work integrated rather than detached? | Pass | Related work is merged into the Introduction and organized around BO cold start, charging accelerators, LLM--BO authority, and the remaining gap. |
| Does each results paragraph separate observation from interpretation? | Pass | The prose reports trends and limitations, while exact values and study-specific qualifications are confined to Tables I--IV and short notes. |

## 3. Experimental evidence

| Reviewer question | Status | Final assessment |
|---|---|---|
| Are the principal results internally consistent? | Pass | Table II matches the evidence matrix for both cell models; the Abstract, Introduction, Results, and Conclusion use only the supported trend-level interpretation. |
| Are small-sample results overstated? | Pass | The main comparison is explicitly descriptive, and the prompt-study significance detail appears only in Table IV and its note. |
| Are HV scales compared correctly? | Pass | Comparisons are within each cell parameterization; absolute Chen2020 and Ecker2015 HV values are not compared across rows. |
| Are strong alternative acquisitions matched? | Needs new experiment | qEHVI/qNEHVI are cited but not run under the same budget and initialization database. |

## 4. Figures and page layout

| Reviewer question | Status | Final assessment |
|---|---|---|
| Are the author-supplied conceptual figures preserved? | Pass | Fig. 1 uses the original problem-formulation artwork and Fig. 2 uses the original Draw.io workflow PDF without redrawing either image. |
| Are experimental visuals placed in their narrative role? | Pass | The platform, Ecker auxiliary panel, Pareto/trajectory pair, component diagnostics, and preprocessing figure are all retained from the original manuscript and placed after their first citation. |
| Are independent figures separated from primary evidence? | Pass | The Ecker panel is identified as an auxiliary comparison under an independent protocol, and the component figure is interpreted qualitatively alongside the table. |
| Is pagination natural? | Pass | The final IEEE two-column paper is 10 pages, contains no forced body-section breaks, and uses balanced reference columns on the last page. |

## 5. Scope and reproducibility

| Reviewer question | Status | Final assessment |
|---|---|---|
| Is the third objective described honestly? | Pass | The degradation quantity is an arbitrary-unit, trajectory-averaged proxy, not measured capacity loss or lifetime. |
| Does the platform imply hardware validation? | Pass | Its caption and setup text state that no platform measurement enters the paper. |
| Are unresolved validation gaps visible? | Pass | Identical-initial-database comparisons, synchronized component runs, matched qEHVI/qNEHVI, calibrated aging, and physical replay are listed as future experiments. |

## Final disposition

The revised manuscript is structurally and numerically consistent with the
current evidence matrix. Remaining risks are empirical rather than editorial:
modest effects, unmatched acquisition baselines, nonidentical initialization
mechanisms, separately controlled component comparisons, an uncalibrated
degradation proxy, and no physical-cell validation.
